US OptionsDetailed Quotes

ESPR241220C2500

Watchlist

0.05
-0.05-50.00%

15min DelayTrading Dec 16 11:34 ET

0.15High0.05Low

Esperion Therapeutics Stock Discussion

Youngman

1 hour ago

$Esperion Therapeutics (ESPR.US)$ 🚀🚀🚀

Gardenia Roti

9 hours ago

I saw a cat

$Esperion Therapeutics (ESPR.US)$
money flow is like a lazy cat... what sign is this?

10xStockPicks

16 hours ago

A.i Predicts Big Pharma Will Soon Acquire Esperion Therapeutics for $12 to $16 A share, Current Price $2.25

$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...

10xStockPicks

18 hours ago

Buying This Takeover Target Offers 10X Upside. Esperion Therapeutics.

$Esperion Therapeutics (ESPR.US)$ $Esperion Therapeutics (ESPR.US)$ Esperion Therapeutics (ESPR) is a biotech company that focuses on developing and commercializing therapies to lower cholesterol, specifically offering the only FDA-approved statin alternatives: NEXLIZET and NEXLETOL for PRIMARY PREVENTION. These drugs are designed for individuals who are statin intolerant or cannot achieve adequate cholesterol lowering with statin...

10xStockPicks

Dec 14 21:19

This $2.25 Stock Soon To Turn A Profit Is Highly Likely To Be Acquired Above $10

This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...

AB84

Dec 13 09:10

Hold

$Esperion Therapeutics (ESPR.US)$ 10 bagger one of these days

UnluckyDog

Dec 13 08:13

$Esperion Therapeutics (ESPR.US)$
gone for good ? 😢

DazzlerAus

Dec 12 08:35

$Esperion Therapeutics (ESPR.US)$

Jaguar8

Dec 12 07:07

NEWS

$Esperion Therapeutics (ESPR.US)$
Esperion Partners with Neopharm to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Israel
Esperion Therapeutics (NASDAQ: ESPR) has entered into a licensing agreement with Neopharm Israel for exclusive commercialization rights of NEXLETOL® and NEXLIZET® in Israel. The agreement includes an upfront payment, near-term milestone payments, and tiered royalties on product sales.
Under the agreement terms, Neopharm will rece...

Trytosaveabit

Dec 12 07:02

Update

$Esperion Therapeutics (ESPR.US)$ Reuters
1 min ago
Esperion Partners With Neopharm to Commercialize Nexletol® (Bempedoic Acid) and Nexlizet® (Bempedoic Acid and Ezetimibe) in Israel! Esperion Therapeutics Inc: Under Terms of Agreement, Esperion Will Receive an Upfront and Near-Term Milestone Payments

No comment yet